
Amanda Andersson-Rolf
Hubrecht Institute for Developmental Biology and Stem Cell Research
Amanda Andersson-Rolf studied medical biotechnology at the Royal Institute of Technology (Stockholm, Sweden) as an undergraduate. She then moved to the UK, where she received her PhD from Cambridge University (the Department of Genetics, at the Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK). Her thesis work in the group of Dr. Bon-Kyoung Koo focused on the development of CRISPR-based gene editing methods and their application in 2D and 3D stem cell cultures. Amanda then joined the lab of Prof. Hans Clevers as a postdoctoral researcher at the Hubrecht Institute of Developmental Biology and Stem Cell Research (Utrecht, Netherlands). Her current research focuses on adult stem cells of the gastrointestinal tract.

Helmuth Gehart
ETH Zürich Institute of Molecular Health Sciences
Helmuth Gehart is Assistant Professor for Tumor and Stem Cell Dynamics at ETH Zurich. Helmuth was born in Vienna, Austria and was, from an early age, fascinated with the complex machinery that is our body. Therefore, he studied molecular biology at the University of Vienna. Subsequently, he moved to Switzerland, where he received his PhD from ETH Zurich. During his PhD training with Romeo Ricci, Helmuth studied the mechanisms behind type 2 diabetes and the complex cellular checkpoints that maintain balance to prevent disease. Thereafter, Helmuth aimed to combine his knowledge of signaling and metabolism with the fascinating field of stem-cell biology. Thus, he joined the group of Hans Clevers in Utrecht, Netherlands, where he investigated adult tissue stem cells in the liver and intestine and their use in clinical research and regenerative medicine. Since 2020, Helmuth has lead his own research group at ETH Zurich, where he studies the dynamic interactions of stem cells and cancer cells with the help of mouse genetics, single-cell sequencing, and organoid technology.
Throughout the life of an organism, stem cells play a key role in both health and disease. During embryonic development, pluripotent stem cells (PSCs) drive the formation of the organism with their capacity to self-renew and develop into any cell of the three germ layers. During adulthood, the regenerative capacity of the body rests in adult stem cells, which are able to self-renew, but restricted to differentiate into cells of the organ in which they reside.
The ability to both self-renew and differentiate has made stem cells invaluable for studying processes such as tissue homeostasis and active regeneration. Additionally, many diseases are characterized by loss or uncontrolled gain of regenerative potential. Stem cell cultures can model these disease mechanisms by using patient-derived material or by targeted genetic manipulation of healthy stem cells.
Recent years have led to the development of 3D culture systems in which both induced PSCs and adult stem cells derived from healthy individuals or patients self-organise and form organoids containing both differentiated cells and stem cells. This has opened up new possibilities to study organ morphogenesis and regenerative medicine. Likewise, organoid technology facilitates the culture of cancer cells that maintain the heterogeneity, resistances, and vulnerabilities of the original tumour.
The aim of this Methods Collection is to bring together techniques used to study and manipulate stem cells in 3D culture during homeostasis and disease and to increase accessibility of organoid technology for a wide range of research fields.
0 Views
•
Cited by 13
•
2021
•
Alejandro Lopez Gonzalez*1, Léa Luciana*1, Clémentine Le Nevé2, Julie Valantin2, Laura Francols2, Nicolas Gadot2, Christophe Vanbelle3, Laurianne Davignon4, Laura Broutier1
1Childhood Cancer & Cell Death (C3), Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon (CRCL), Lyon 69373, 2Plateforme Anatomopathologie Recherche, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon (CRCL), 3Plateforme d’Imagerie cellulaire, Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon (CRCL), 4PerkinElmer S.A.S.
0 Views
•
Cited by 3
•
2022
•
1Key Laboratory of Experimental Teratology, Ministry of Education, Institute of Molecular Medicine and Genetics, School of Basic Medical Sciences, Stem Cell and Regenerative Medicine Research Center, Cheeloo College of Medicine, Shandong University, 2The Research Center of Stem Cell and Regenerative Medicine, Shandong University Cheeloo Medical College, School of Basic Medical Sciences, Shandong University
0 Views
•
Cited by 17
•
2021
•
Marrit Putker*1, Rosemary Millen*2, René Overmeer*3, Else Driehuis2,4, Maurice M. J. M. Zandvliet5, Hans Clevers2, Sylvia F. Boj3, Qi-Xiang Li6
1Crown Bioscience Netherlands B.V., 2Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, 3Hubrecht Organoid Technology (HUB), 4Pathology dept, University Medical Center Utrecht, 5Department of Clinical Sciences - Companion Animals, Faculty of Veterinary Medicine, Utrecht University, 6Crown Bioscience Inc.
0 Views
•
Cited by 7
•
2021
•
Artem Eremeev1,3, Lilia Belikova1,2, Evgeny Ruchko1, Egor Volovikov1,5, Olga Zubkova1, Alexy Emelin4, Roman Deev4, Olga Lebedeva1,3, Alexandra Bogomazova1,3, Maria Lagarkova1,3
1Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency, 2Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 3Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Federal Research and Clinical Center of Physical-Chemical Medicine, Federal Medical Biological Agency, 4Department of Pathological Anatomy, North-Western State Medical University, 5Department of Biology, Lomonosov State University
0 Views
•
Cited by 9
•
2021
•
Stephanie Le1, Laura Petersilie2, Gizem Inak1,4, Carmen Menacho-Pando1, Karl W. Kafitz2, Agnieszka Rybak-Wolf3, Nikolaus Rajewsky3, Christine R. Rose2, Alessandro Prigione1,5
1Department of General Pediatrics, Neonatology and Pediatric Cardiology, Duesseldorf University Hospital, Medical Faculty, Heinrich Heine University, 2Institute of Neurobiology, Heinrich Heine University, 3Berlin Institute for Medical Systems Biology (BIMSB), Max Delbrueck Center for Molecular Medicine (MDC), 4Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, 5Max Delbrueck Center for Molecular Medicine (MDC)
0 Views
•
Cited by 1
•
2024
•
1Institute of Hematology, Department of Hematology, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 2The Lab of Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, 3Precision Medicine Research Laboratory, West China Hospital, Sichuan University